Medical Device Stocks
Recent market-moving SEC filings and news across medical device companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a medical device company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksPharmaceutical StocksHealth Tech StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
IRIDEX Issues Shares to 10% Owner for Convertible Note Interest Payment
Aethlon Medical Secures $4.0M in Highly Dilutive Registered Offering at $0.71
Bone Biologics Secures $3M Upfront, Potentially $9M, in Private Placement Amid Going Concern
Aethlon Medical Closes Highly Dilutive $3.3M Offering, Issues Over 11M Shares/Warrants
Vivos Therapeutics Raises $2.1M in PIPE, Securing Critical Liquidity
Vivos Therapeutics Secures $2.1M in Dilutive Equity Financing to Address Liquidity Needs
Shareholders Approve Massive Dilution; Preferred Stock Converts, Adding 27.6M Shares with 28.9M More Pending
Valion Bio Seeks Shareholder Approval for Reverse Stock Split to Avoid Nasdaq Delisting
Sands Capital's Board Representation Ends Following Director's Passing
AdaptHealth to Redeem $325M Senior Notes, Leveraging Existing Credit Facility
Lifeward Secures $5.58M in Initial Tranche of $11.16M Convertible Note and Warrant Financing at a Discount
Nuwellis Seeks Shareholder Approval for Massive Warrant Dilution and Further Reverse Split Authority
Lifeward Secures $11.2M Capital Infusion to Accelerate Growth
Aethlon Medical Finalizes $4.0M Offering with 237% Immediate Dilution and Warrants
Officer/Director Files Intent to Sell $780K in Ceribell Stock
Profusa's 1-for-25 reverse stock split fails to stem price collapse; updates prospectus for ongoing dilutive financing
Profusa Files Prospectus Supplement for Resale of 7.17M Shares, Enabling Massive Dilution Post-Split
Profusa Effects 1-for-25 Reverse Stock Split, Registers Shares for Resale Amidst Financial Distress
Profusa Finalizes 1-for-25 Reverse Stock Split Amidst Further Dilution from Convertible Note Resale
SS Innovations Subsidiary Graduates First Robotic Cardiac Surgery Training Class
Streamex to Repurchase Up to 10M Shares, Stock Jumps 14%
Profusa Announces 1-for-25 Reverse Stock Split Amidst Delisting Threats, Enabling Extreme Dilution
RxSight Lowers Full-Year Sales Guidance Amidst Q2 Commercial Headwinds
RxSight Secures Major Collaboration with Alcon, Receives $60M Upfront Payment
RxSight Lowers Full-Year Sales Guidance to $110-$120M, Citing Q2 Competitive Pressures
RxSight Secures $60M Upfront, Up to $140M Milestones in Alcon PCIOL Development Deal
Cytosorbents Receives Nasdaq Delisting Notice for Low Market Value
IceCure's ProSense™ Cryoablation Sees Growing Commercial Adoption in Brazil Following FDA Clearance
Law Firm Investigates iRhythm Insiders for Breach of Fiduciary Duties
Law Firm Investigates Bioventus Insiders for Fiduciary Duty Breach
Sintx Technologies Restructures Warrants, Issues Shares to Address Balance Sheet and Nasdaq Compliance
Director Raymond Cohen Resigns from InspireMD Board and Key Committees
AdaptHealth Discloses Material Cybersecurity Breach, Patient Data and Billing Passwords Stolen
CMS Reverses Bone Growth Stimulator Reimbursement Cut, Boosting Orthofix
Shareholders to Vote on Deeply Discounted Warrant Exercise Price to Raise Capital
Tenon Medical Secures $4.2M Equity Offering, Issues Warrants at $0.38 Amid Delisting Threat
Pulsenmore Files F-1 for Resale of 3.125M Shares, Potential 48% Dilution
Tenon Medical Closes $4.2 Million Public Offering Amidst Delisting Threat
AdaptHealth Discloses Material Cybersecurity Incident Involving Patient Data
CMS Reverses Reimbursement Changes for Bone Growth Stimulators